Home Other Building Blocks 63329-53-3
63329-53-3,MFCD00866065
Catalog No.:AA00EACF

63329-53-3 | Lobenzarit

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
98%
1 week  
$369.00   $259.00
- +
100mg
98%
1 week  
$575.00   $403.00
- +
250mg
98%
1 week  
$963.00   $675.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00EACF
Chemical Name:
Lobenzarit
CAS Number:
63329-53-3
Molecular Formula:
C14H10ClNO4
Molecular Weight:
291.6865
MDL Number:
MFCD00866065
SMILES:
C1=CC=C(C(=C1)C(=O)O)NC2=C(C=CC(=C2)Cl)C(=O)O
Properties

Downstream Synthesis Route

[1]Denny;Atwell;Baguley[JournalofMedicinalChemistry,1983,vol.26,#11,p.1619-1625]

[2]Stewart,GeorginaM.;Rewcastle,GordonW.;Denny,WilliamA.[AustralianJournalofChemistry,1984,vol.37,#9,p.1939-1950]

[3]Stewart,GeorginaM.;Rewcastle,GordonW.;Denny,WilliamA.[AustralianJournalofChemistry,1984,vol.37,#9,p.1939-1950]

[1]Denny,WilliamA.;Cain,BruceF.;Atwell,GrahamJ.;Hansch,Corwin;Panthananickal,Augustine;Leo,A.[JournalofMedicinalChemistry,1982,vol.25,#3,p.276-300]

[2]Zhang,Bin;Chen,Kang;Wang,Ning;Gao,Chunmei;Sun,Qinsheng;Li,Lulu;Chen,Yuzong;Tan,Chunyan;Liu,Hongxia;Jiang,Yuyang[EuropeanJournalofMedicinalChemistry,2015,vol.93,p.214-226]

[3]CurrentPatentAssignee:SHENZHENKUNJIANINNOVATIVEDRUGRESINST-CN104262327,2016,BLocationinpatent:Paragraph0211-0212

[4]CurrentPatentAssignee:MEDICALCOLLEGEOFWISCONSIN-WO2022/174085,2022,A1Locationinpatent:Paragraph0315

[5]CurrentPatentAssignee:MEDICALCOLLEGEOFWISCONSIN-WO2022/174085,2022,A1Locationinpatent:Paragraph0315

[6]Shishodia,Shifali;Nuñez,Raymundo;Strohmier,BraydenP.;Bursch,KarinaL.;Goetz,ChristopherJ.;Olp,MichaelD.;Jensen,DavinR.;Fenske,TylerG.;Ordonez-Rubiano,SandraC.;Blau,MayaE.;Roach,MalloryK.;Peterson,FrancisC.;Volkman,BrianF.;Dykhuizen,EmilyC.;Smith,BrianC.[JournalofMedicinalChemistry,2022,vol.65,#20,p.13714-13735]

[7]Shishodia,Shifali;Nuñez,Raymundo;Strohmier,BraydenP.;Bursch,KarinaL.;Goetz,ChristopherJ.;Olp,MichaelD.;Jensen,DavinR.;Fenske,TylerG.;Ordonez-Rubiano,SandraC.;Blau,MayaE.;Roach,MalloryK.;Peterson,FrancisC.;Volkman,BrianF.;Dykhuizen,EmilyC.;Smith,BrianC.[JournalofMedicinalChemistry,2022,vol.65,#20,p.13714-13735]

[1]Zhang,Bin;Chen,Kang;Wang,Ning;Gao,Chunmei;Sun,Qinsheng;Li,Lulu;Chen,Yuzong;Tan,Chunyan;Liu,Hongxia;Jiang,Yuyang[EuropeanJournalofMedicinalChemistry,2015,vol.93,p.214-226]

[2]CurrentPatentAssignee:SHENZHENKUNJIANINNOVATIVEDRUGRESINST-CN104262327,2016,BLocationinpatent:Paragraph0206-0208

[3]Denny;Atwell;Baguley[JournalofMedicinalChemistry,1983,vol.26,#11,p.1619-1625]

[4]Eissa,AmalAbdelHaleemMohamed;Soliman,GamalAbdEl-Hakeem;Khataibeh,MoayadHussein[Chemicalandpharmaceuticalbulletin,2012,vol.60,#10,p.1290-1300,11]

[1]Denny;Atwell;Baguley[JournalofMedicinalChemistry,1983,vol.26,#11,p.1619-1625]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Building Blocks
More >
Tags:63329-53-3 Molecular Formula|63329-53-3 MDL|63329-53-3 SMILES|63329-53-3 Lobenzarit